Anoro ellipta and Platelet count increased - a phase IV clinical study of FDA data

Summary:

Platelet count increased is reported as a side effect among people who take Anoro ellipta (umeclidinium bromide; vilanterol trifenatate), especially for people who are male, 50-59 old, also take Metformin, and have Arthritis infective.

The phase IV clinical study analyzes which people have Platelet count increased when taking Anoro ellipta. It is created by eHealthMe based on reports of 16,408 people who have side effects when taking Anoro ellipta from the FDA, and is updated regularly.

What is Anoro ellipta?

Anoro ellipta has active ingredients of umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 16,515 Anoro ellipta users. Check the latest studies of Anoro ellipta.

What is Platelet count increased?

Platelet count increased is found to be associated with 955 drugs and 1,190 conditions by eHealthMe. Check the latest studies of Platelet count increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

16,408 people reported to have side effects when taking Anoro ellipta.
Among them, 18 people (0.11%) have Platelet count increased.

Could Anoro ellipta cause Platelet count increased?

Among these 18 people:

What is the gender of people who have Platelet count increased when taking Anoro ellipta? *

female: 0.0 %
male: 100 %

What is the age of people who have Platelet count increased when taking Anoro ellipta? *

What are other drugs people take besides Anoro ellipta? *

What are other side effects people have besides Platelet count increased? *

Blood Creatinine Increased: 16 people, 88.89%
Fever: 16 people, 88.89%
C-Reactive Protein Increased: 15 people, 83.33%
Laboratory Test Abnormal: 14 people, 77.78%
White Blood Cell Count Increased: 1 person, 5.56%
Dyspnea (difficult or laboured breathing): 1 person, 5.56%
Glomerular Filtration Rate Decreased: 1 person, 5.56%
Gastritis (inflammation of stomach): 1 person, 5.56%
Gastric Ulcer (stomach ulcer): 1 person, 5.56%
Fatigue (feeling of tiredness): 1 person, 5.56%

What are the existing conditions these people have? *

Osteomyelitis (infection of bone): 16 people, 88.89%
High Blood Pressure: 16 people, 88.89%
Arthritis Infective (purulent invasion of a joint by an infectious agent which produces arthritis): 16 people, 88.89%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Anoro ellipta and have Platelet count increased?

- Check whether Platelet count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anoro ellipta:

Anoro ellipta (16,515 reports)

Platelet count increased treatments and more:

Platelet count increased (18,565 reports)

How severe was Platelet count increased and when was it recovered:

Platelet count increased in Anoro ellipta

Expand to all the drugs that have ingredients of umeclidinium bromide; vilanterol trifenatate:

Platelet count increased and drugs with ingredients of umeclidinium bromide; vilanterol trifenatate (18 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Anoro ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Platelet count increased:

Platelet count increased (955 drugs)

Browse all the conditions that are associated with Platelet count increased:

Platelet count increased (1,190 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on umeclidinium bromide; vilanterol trifenatate (the active ingredients of Anoro ellipta) and Anoro ellipta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.